This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Nov 1;9(11):1589.

doi: 10.1001/jamaoncol.2023.3651.

Risk of Death Due to Pregnancy-Associated Cancers-More Questions Than Answers-Reply

Zoe F Cairncross¹, Gregg Nelson¹, Amy Metcalfe^{1

2

3}

Affiliations

Affiliations

¹ Department of Obstetrics and Gynecology, University of Calgary, Calgary, Canada.
² Department of Community Health Sciences, University of Calgary, Calgary, Canada.
³ Department of Medicine, University of Calgary, Calgary, Canada.

PMID: 37733360
DOI: 10.1001/jamaoncol.2023.3651

Comment

Risk of Death Due to Pregnancy-Associated Cancers-More Questions Than Answers-Reply

Zoe F Cairncross et al. JAMA Oncol. 2023.

. 2023 Nov 1;9(11):1589.

doi: 10.1001/jamaoncol.2023.3651.

Authors

Zoe F Cairncross¹, Gregg Nelson¹, Amy Metcalfe^{1

2

3}

Affiliations

¹ Department of Obstetrics and Gynecology, University of Calgary, Calgary, Canada.
² Department of Community Health Sciences, University of Calgary, Calgary, Canada.
³ Department of Medicine, University of Calgary, Calgary, Canada.

PMID: 37733360
DOI: 10.1001/jamaoncol.2023.3651

No abstract available

PubMed Disclaimer

Comment on

Risk of Death Due to Pregnancy-Associated Cancers-More Questions Than Answers.
Silverstein J, Van Loon K. Silverstein J, et al. JAMA Oncol. 2023 Nov 1;9(11):1588-1589. doi: 10.1001/jamaoncol.2023.3648. JAMA Oncol. 2023. PMID: 37733335 No abstract available.

Similar articles

Risk of Death Due to Pregnancy-Associated Cancers-More Questions Than Answers.
Silverstein J, Van Loon K. Silverstein J, et al. JAMA Oncol. 2023 Nov 1;9(11):1588-1589. doi: 10.1001/jamaoncol.2023.3648. JAMA Oncol. 2023. PMID: 37733335 No abstract available.
Reply to D. Crivellari et al.
Theriault RL, Litton JK. Theriault RL, et al. J Clin Oncol. 2014 Jan 20;32(3):256-7. doi: 10.1200/JCO.2013.53.1020. Epub 2013 Dec 2. J Clin Oncol. 2014. PMID: 24297948 No abstract available.
Reply to D. Crivellari et al.
Han SN, Loibl S, Van Calster B, Neven P, Nekljudova V, Amant F. Han SN, et al. J Clin Oncol. 2014 Jan 20;32(3):255-6. doi: 10.1200/JCO.2013.53.1012. Epub 2013 Dec 2. J Clin Oncol. 2014. PMID: 24297941 No abstract available.
Malignant melanoma and the prognostic implications of pregnancy, oral contraceptives, and exogenous hormones.
Slingluff CL Jr, Reintgen D. Slingluff CL Jr, et al. Semin Surg Oncol. 1993 May-Jun;9(3):228-31. Semin Surg Oncol. 1993. PMID: 8516609 Review.
Myeloproliferative disorders in pregnancy.
Harrison CN, Robinson SE. Harrison CN, et al. Hematol Oncol Clin North Am. 2011 Apr;25(2):261-75, vii. doi: 10.1016/j.hoc.2011.01.008. Hematol Oncol Clin North Am. 2011. PMID: 21444029 Review.

See all similar articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Grants and funding

CIHR/Canada

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information